Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00856219 · ClinicalTrials.gov registry record · Phase 1
Comparison of Enteral Versus Parenteral Feeding in Healthy Human Subjects
A Phase 1 study, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT00856219: Completed Phase 1 study, sponsored by Rutgers, The State University of New Jersey.
NCT00856219 is a Phase 1 study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 12 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00856219, a Phase 1 study, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
Literature suggests that route of feeding and/or certain nutrients may cause alterations in the body's immune cells. Immune cells help protect the body and fight infection/disease. Tube feeding (TF) is a method of delivering nutrition directly to the stomach/intestines via a small tube. The immune system may respond differently when receiving continuous TF as compared to receiving intermittent TF. Heart rate variability (HRV, the intervals between heartbeats) is a measurement of the nervous system's response to a stress/illness. The differences in immune cells and/or HRV may influence how the body reacts to complications such as infection.
Interventions
- DIETARY_SUPPLEMENT Enteral Continuous
- DIETARY_SUPPLEMENT Enteral Intermittent
- DIETARY_SUPPLEMENT Parenteral Continuous
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2009-02 |
| Est. Completion | 2011-03 |
| Phase | Phase 1 |
What the finished NCT00856219 record still lists
NCT00856219 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (80% lower).
The record links to 0 conditions, and to 3 interventions - of which Enteral Continuous is the first listed.
NCT00856219 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00856219 about?
NCT00856219 is a clinical study titled "Comparison of Enteral Versus Parenteral Feeding in Healthy Human Subjects". Literature suggests that route of feeding and/or certain nutrients may cause alterations in the body's immune cells. Immune cells help protect the body and fight infection/disease. Tube feeding (TF) is a method of delivering nutrition directly to the stomach/intestines via a small tube. The immune s...
What is the current status of trial NCT00856219?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2009-02. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00856219?
The interventions under investigation include: Enteral Continuous (DIETARY_SUPPLEMENT), Enteral Intermittent (DIETARY_SUPPLEMENT), Parenteral Continuous (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00856219?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00856219's enrollment target sits among peer trials
12 1852nd of 2000 higher than 90 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia